Chain Reaction Innovations (CRI), the entrepreneurship program at The U.S. Department of Energy’s (DOE) Argonne National Laboratory, is now accepting applications for its Cohort 7. Entrepreneurs with clean energy and climate technology innovations who can leverage Argonne’s resources are encouraged to apply.
CRI propels the next generation of energy entrepreneurs by helping them move their innovations to market. A new cohort is selected each year through an annual call for applications. This year, the application period is open through 5 p.m. CST on Nov. 30. Those chosen for Cohort 7 will begin work in summer 2023. Any individual interested in developing a startup technology aligned with an Argonne research area, including quantum science and engineering, is encouraged to apply.
“CRI is dedicated to inclusive innovation. We’re proud to have a diverse set of innovators who share their unique perspectives, bring new ideas, and provide valuable insights to all who participate,” said Deena Wright, CRI’s senior program specialist who works with the cohorts. “Our goal is to make sure the startups in our program graduate with a strong foundation of business knowledge, while also developing their technologies.”
To apply or learn more, visit CRI’s website.
Informational Webinars
CRI will host informational webinars in November for interested applicants to learn specifics about the program. In addition, CRI staff will hold Zoom office hours to answer individual questions. If selected, innovators receive salary, benefits, travel expenses and support for technical work at Argonne.
Tuesday, Nov. 8 from 1-2 p.m. CST
Monday, Nov. 28 from 3-4 p.m. CST
Cohort 7 Fellowships
- Up to $110,000 per year for salary stipend, and $12,000 for travel plus moving expenses.
- Benefits include healthcare, with family option.
- Up to $220,000 for technical work at Argonne.
- Extensive entrepreneurial training for first-time founders, plus ongoing programming.
- Networking opportunities with business experts, investors, mentors, CRI cohorts and corporate partners.
- Mentorship and support from the CRI team, plus technical expertise from Argonne researchers.
- Argonne takes no equity stake.